Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
BME Quote, Financials, Valuation and Earnings
Last price:
$35.89
Seasonality move
:
-0.79%
Day range:
$35.81 - $36.19
52-week range:
$34.18 - $42.64
Dividend yield:
6.52%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
40.7K
Avg. volume:
42.8K
1-year change:
-14.33%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
$35.88 | -- | -- | -- | $0.26 | 6.52% | -- |
|
AGNG
Global X Aging Population ETF
|
$32.20 | -- | -- | -- | $0.14 | 0.9% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.04 | -- | -- | -- | $0.17 | 11.17% | -- |
|
HQH
abrdn Healthcare Investors
|
$15.77 | -- | -- | -- | $0.54 | 7.04% | -- |
|
HRTS
Tema Heart & Health ETF
|
$28.58 | -- | -- | -- | $0.47 | 0.5% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$28.44 | -- | -- | -- | $0.06 | 0.78% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | 0.612 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.588 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.021 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 0.967 | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | 0.652 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.851 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
Blackrock Health Sciences Trust vs. Competitors
-
Which has Higher Returns BME or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About BME or AGNG?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Global X Aging Population ETF, analysts believe Blackrock Health Sciences Trust is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is BME or AGNG More Risky?
Blackrock Health Sciences Trust has a beta of 0.676, which suggesting that the stock is 32.401% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.736, suggesting its less volatile than the S&P 500 by 26.45%.
-
Which is a Better Dividend Stock BME or AGNG?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 6.52%. Global X Aging Population ETF offers a yield of 0.9% to investors and pays a quarterly dividend of $0.14 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or AGNG?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns BME or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About BME or BMEZ?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than BlackRock Health Sciences Trust II, analysts believe Blackrock Health Sciences Trust is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is BME or BMEZ More Risky?
Blackrock Health Sciences Trust has a beta of 0.676, which suggesting that the stock is 32.401% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 1.069, suggesting its more volatile than the S&P 500 by 6.85%.
-
Which is a Better Dividend Stock BME or BMEZ?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 6.52%. BlackRock Health Sciences Trust II offers a yield of 11.17% to investors and pays a quarterly dividend of $0.17 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or BMEZ?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns BME or HQH?
abrdn Healthcare Investors has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About BME or HQH?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than abrdn Healthcare Investors, analysts believe Blackrock Health Sciences Trust is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is BME or HQH More Risky?
Blackrock Health Sciences Trust has a beta of 0.676, which suggesting that the stock is 32.401% less volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.806, suggesting its less volatile than the S&P 500 by 19.424%.
-
Which is a Better Dividend Stock BME or HQH?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 6.52%. abrdn Healthcare Investors offers a yield of 7.04% to investors and pays a quarterly dividend of $0.54 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or HQH?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns BME or HRTS?
Tema Heart & Health ETF has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Tema Heart & Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- HRTSTema Heart & Health ETF-- -- -- -
What do Analysts Say About BME or HRTS?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Heart & Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Tema Heart & Health ETF, analysts believe Blackrock Health Sciences Trust is more attractive than Tema Heart & Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 HRTSTema Heart & Health ETF0 0 0 -
Is BME or HRTS More Risky?
Blackrock Health Sciences Trust has a beta of 0.676, which suggesting that the stock is 32.401% less volatile than S&P 500. In comparison Tema Heart & Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BME or HRTS?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 6.52%. Tema Heart & Health ETF offers a yield of 0.5% to investors and pays a quarterly dividend of $0.47 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Tema Heart & Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or HRTS?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Tema Heart & Health ETF quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Tema Heart & Health ETF's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Tema Heart & Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Tema Heart & Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- HRTSTema Heart & Health ETF-- -- -- --
-
Which has Higher Returns BME or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to Blackrock Health Sciences Trust's net margin of --. Blackrock Health Sciences Trust's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMEBlackrock Health Sciences Trust-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About BME or RSPH?
Blackrock Health Sciences Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Blackrock Health Sciences Trust has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe Blackrock Health Sciences Trust is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings BMEBlackrock Health Sciences Trust0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is BME or RSPH More Risky?
Blackrock Health Sciences Trust has a beta of 0.676, which suggesting that the stock is 32.401% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.971%.
-
Which is a Better Dividend Stock BME or RSPH?
Blackrock Health Sciences Trust has a quarterly dividend of $0.26 per share corresponding to a yield of 6.52%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.78% to investors and pays a quarterly dividend of $0.06 per share. Blackrock Health Sciences Trust pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BME or RSPH?
Blackrock Health Sciences Trust quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. Blackrock Health Sciences Trust's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, Blackrock Health Sciences Trust's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Blackrock Health Sciences Trust is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMEBlackrock Health Sciences Trust-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
